Discovery of Small-Molecule Inhibitors Against Norovirus 3CLpro Using Structure-Based Virtual Screening and FlipGFP Assay
Viruses · 2025
DOI: 10.3390/v17060814 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Hao Shen und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China. Hauptthemen laut MEDLINE: Norovirus, Antiviral Agents, Viral Proteins, Small Molecule Libraries. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangzhou National Laboratory.
Abstract (Originalsprache)
Norovirus, a major cause of acute gastroenteritis, possesses a single-stranded positive-sense RNA genome. The viral 3C-like cysteine protease (3CLpro) plays a critical role in processing the viral polyprotein into mature non-structural proteins, a step essential for viral replication. Targeting 3CLpro has emerged as a promising strategy for developing small-molecule inhibitors against Norovirus. In this study, we employed a combination of virtual screening and the FlipGFP assay to identify potential inhibitors targeting the 3CLpro of Norovirus genotype GII.4. A library of approximately 58,800 compounds was screened using AutoDock Vina tool, yielding 20 candidate compounds based on their Max Affinity scores. These compounds were subsequently evaluated using a cell-based FlipGFP assay. Among them, eight compounds demonstrated significant inhibitory activity against 3CLpro, with Gedatolisib showing the most potent effect (IC50 = 0.06 ± 0.01 μM). Molecular docking and molecular dynamics simulations were conducted to explore the binding mechanisms and structural stability of the inhibitor–3CLpro complexes. Our findings provide valuable insights into the development of antiviral drugs targeting Norovirus 3CLpro, offering potential therapeutic strategies to combat Norovirus infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
- State Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China.
- School of Pharmaceutical Sciences, Peking University, Beijing 100091, China.
- AI for Science Institute, Beijing 100085, China.
ORCID-Profile: Mingyang Zhang, Jian Wang
Förderung
- Guangzhou National Laboratory
Zitieren
APA
Shen, H., Liu, S., Shang, L., Liu, Y., Sha, Y., Lei, D., Zhang, Y., Jin, C., Wu, S., Zhang, M., Wen, H., Jia, C., & Wang, J. (2025). Discovery of Small-Molecule Inhibitors Against Norovirus 3CLpro Using Structure-Based Virtual Screening and FlipGFP Assay. Viruses. https://doi.org/10.3390/v17060814
Vancouver
Shen H, Liu S, Shang L, Liu Y, Sha Y, Lei D, et al. Discovery of Small-Molecule Inhibitors Against Norovirus 3CLpro Using Structure-Based Virtual Screening and FlipGFP Assay. Viruses. 2025. doi:10.3390/v17060814
BibTeX
@article{Shen2025,
author = {Shen, Hao and Liu, Shiqi and Shang, Limin and Liu, Yuchen and Sha, Yijin and Lei, Dingwei and Zhang, Yuehui and Jin, Chaozhi and Wu, Shanshan and Zhang, Mingyang and Wen, Han and Jia, Chenxi and Wang, Jian},
title = {Discovery of Small-Molecule Inhibitors Against Norovirus 3CLpro Using Structure-Based Virtual Screening and FlipGFP Assay},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17060814}
}
EUVIMED